Volatile Stocks: Canadian Solar (NASDAQ:CSIQ), Genetic Technologies (NASDAQ:GENE), Dendreon (NASDAQ:DNDN), Arena Pharmaceuticals (NASDAQ:ARNA)

Canadian Solar Inc. (NASDAQ:CSIQ) on July 7th, 2014 announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., on June 30th, completed the sale of the 10 MW AC solar photovoltaic (PV) power plant “Val Caron” valued at over CAD 60 million to One West Holdings Ltd., an affiliate of Concord Green Energy. Canadian Solar Inc. (NASDAQ:CSIQ) stock performance was -3.19% in last session and finished … Continue reading Volatile Stocks: Canadian Solar (NASDAQ:CSIQ), Genetic Technologies (NASDAQ:GENE), Dendreon (NASDAQ:DNDN), Arena Pharmaceuticals (NASDAQ:ARNA)

Hot Movers: National Bank of Greece (ADR) (NYSE:NBG), Dendreon Corporation (NASDAQ:DNDN), Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), Weibo Corp (ADR) (NASDAQ:WB)

National Bank of Greece (ADR) (NYSE:NBG) was added to the “model portfolio” of JPMorgan’s European banking analysts Monday, who also added Banco Popular to the list following last week’s moves by the European Central Bank to improve funding to the banking sector. National Bank of Greece (ADR) (NYSE:NBG) stock performance was -5.13% in last session and finished the day at $3.88. Traded volume was 8.96million … Continue reading Hot Movers: National Bank of Greece (ADR) (NYSE:NBG), Dendreon Corporation (NASDAQ:DNDN), Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), Weibo Corp (ADR) (NASDAQ:WB)

Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

MannKind Corp. (NASDAQ: MNKD) was raised to Neutral from Underweight by Piper Jaffray. MannKind Corporation (NASDAQ:MNKD) stock performance was 6.53% in last session and finished the day at $7.01. Traded volume was 16.68million shares in the last session and the average volume of the stock remained 10.11million shares. The beta of the stock remained 1.40. MannKind Corporation (NASDAQ:MNKD) insider ownership is 0.30%. Celldex Therapeutics, Inc. … Continue reading Biotech Gainers: MannKind Corporation (NASDAQ:MNKD), Celldex Therapeutics (NASDAQ:CLDX), Dendreon Corporation (NASDAQ:DNDN), Intrexon Corp (NYSE:XON)

NASDAQ Bearish Stocks: Scientific Games Corp (NASDAQ:SGMS), Dendreon Corporation (NASDAQ:DNDN), Depomed Inc (NASDAQ:DEPO), Criteo (NASDAQ:CRTO)

Scientific Games Corporation (NASDAQ:SGMS), a leading diversified supplier of games and technology to the gaming and lottery industries, today reported financial results for the first quarter ended March 31, 2014. Scientific Games Corp (NASDAQ:SGMS) stock performance was -17.07% in last session and finished the day at $8.97. Traded volume was 7.44million shares in the last session and the average volume of the stock remained 1.21million … Continue reading NASDAQ Bearish Stocks: Scientific Games Corp (NASDAQ:SGMS), Dendreon Corporation (NASDAQ:DNDN), Depomed Inc (NASDAQ:DEPO), Criteo (NASDAQ:CRTO)

Healthcare Sector Most Active: Pfizer Inc. (NYSE:PFE), Novavax (NASDAQ:NVAX), Boston Scientific Corporation (NYSE:BSX), Dendreon Corporation (NASDAQ:DNDN)

Pfizer Inc. (NYSE:PFE) has begun testing an over-the-counter version of Lipitor, the blockbuster drug that has plumped up the pharmaceutical giant’s coffers for more than a decade. Pfizer Inc. (NYSE:PFE) stock performance was 2.22% in last session and finished the day at $32.69. Traded volume was 26,325,091 million shares in the last session and the average volume of the stock remained 26.27 million shares. The … Continue reading Healthcare Sector Most Active: Pfizer Inc. (NYSE:PFE), Novavax (NASDAQ:NVAX), Boston Scientific Corporation (NYSE:BSX), Dendreon Corporation (NASDAQ:DNDN)

Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) on Feb. 27 announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering price of $2.90 per share. The gross proceeds to Inovio from this offering are expected to be approximately $55 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. Inovio Pharmaceuticals Inc (NYSEMKT:INO) … Continue reading Biotech Gainers In News: Inovio Pharmaceuticals (NYSEMKT:INO), Dendreon Corporation (NASDAQ:DNDN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax (NASDAQ:DYAX)